Although pMMR CRC tumors are characterized by their lower mutational and neoantigen burden, they express cancer germline antigens and harbor mutated KRAS or p53 proteins against which T-cell responses have been identified [169, 170]. Here, TP53 is linked to colorectal carcinoma.